AIM ImmunoTech joins with ChinaGoAbroad for Ampligen China Entry against COVID-19
- Written by ACN Newswire - Press Releases
OCALA, FL / ACCESSWIRE, Feb 27, 2020 - (ACN Newswire) - AIM ImmunoTech (NYSE American: AIM, or the Company), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that the Company has joined with ChinaGoAbroad (CGA) to facilitate
Read more //?#